Using dual-pathway whole-cell recordings from the same dentate granule cell (GC), the authors delivered a physiologically inspired pre-post burst pairing protocol (6 presynaptic pulses at 50 Hz paired with 5 postsynaptic APs at 100 Hz, 100 repetitions) at medial perforant path (MPP) synapses. This induced homosynaptic NMDAR-LTP at MPP (153.1Β±7.9%, n=11, p<0.001) and heterosynaptic NMDAR-LTP at distal, unstimulated lateral perforant path (LPP) synapses (137.2Β±5.1%, n=11, p<0.001) . Critically, applying the same protocol at LPP induced nothing (105.3Β±4.5%), ruling out stimulation crosstalk, and placing the LPP pipette β₯250 Β΅m lateral (opposite dendritic branches) abolished heterosynaptic plasticity β supporting branch-restricted signaling consistent with dendritic branches as computational units .
Same protocol, opposite AMPAR fate: MPP AMPAR-LTP (163.2Β±15.8%, n=5) co-occurred with LPP AMPAR-LTD (77.7Β±7.6%, n=5), showing NMDAR and AMPAR obey dissociable plasticity rules .
Heterosynaptic β but not homosynaptic β NMDAR-LTP was abolished by depleting internal CaΒ²βΊ stores (CPA: 106.6Β±3.8% vs control 140.5Β±4.2%) and by ryanodine (101.4Β±4.1%), while heparin (IPβR blocker) spared it (124.2Β±4.0%). Both forms required mGluR5 and postsynaptic CaΒ²βΊ (MPEP, BAPTA blocked both). GluN2D dependence was tested three ways: DQP-1105 blocked induction (99.1Β±2.2% vs control 147.8Β±9.1%), antagonists applied post-induction reduced the potentiated component ~85%, and postsynaptic Grin2d conditional knockout abolished heterosynaptic LTP (97.8Β±4.1% vs mCherry control 144.5Β±11.2%) . The authors interpret this as synaptic recruitment of GluN2D-containing NMDARs β plausibly triheteromers β whose low MgΒ²βΊ sensitivity lets distal LPP synapses pass current without strong backpropagating-AP depolarization, and heterosynaptic LTP increased LPP-driven GC firing (two-way RM ANOVA, p=0.004), an effect lost under GluN2D antagonism.
Strengths: interleaved controls, cross-species replication (mouse Figure 1E), confirmation at 32Β°C, effect sizes reported (Hedges' gav, often 3-10), and convergent pharmacology plus cell-autonomous genetics. Limitations the authors acknowledge: sex/estrous effects not powered; ryanodine's biphasic dose-response and possible off-targets . Additional blind spots: all evidence is ex vivo at 28Β°C (main experiments) with 20-30 min endpoints β persistence beyond ~30 min and in vivo relevance are untested; the LPP "no plasticity" result rests on n=5; GluN2C vs GluN2D cannot be distinguished pharmacologically, though forebrain GluN2C expression is argued to be negligible; and the key precursor work (Berthoux et al., 2026) is a preprint . Falsification paths: heterosynaptic LTP persisting despite Grin2d cKO or RyR blockade, or appearing with LPP-only pairing, would refute the model.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.